Muzaffer Arıkan

647 total citations
23 papers, 384 citations indexed

About

Muzaffer Arıkan is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Muzaffer Arıkan has authored 23 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Physiology and 4 papers in Genetics. Recurrent topics in Muzaffer Arıkan's work include Gut microbiota and health (7 papers), Mitochondrial Function and Pathology (4 papers) and Metabolism and Genetic Disorders (3 papers). Muzaffer Arıkan is often cited by papers focused on Gut microbiota and health (7 papers), Mitochondrial Function and Pathology (4 papers) and Metabolism and Genetic Disorders (3 papers). Muzaffer Arıkan collaborates with scholars based in Türkiye, United Kingdom and United States. Muzaffer Arıkan's co-authors include Alex Mitchell, Filiz Gürel, ROBERT FINN, Thilo Muth, Duran Üstek, Aris Çakiris, Neslihan Abacı, Zeliha Emrence, Hülya Azaklı and Süleyman Yıldırım and has published in prestigious journals such as Emerging infectious diseases, Gene and Journal of General Virology.

In The Last Decade

Muzaffer Arıkan

22 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muzaffer Arıkan Türkiye 12 237 63 60 52 45 23 384
Meenakshi Pradhan Sweden 10 322 1.4× 71 1.1× 21 0.3× 45 0.9× 105 2.3× 10 486
Claire E. Kohout United States 5 241 1.0× 49 0.8× 14 0.2× 32 0.6× 41 0.9× 6 330
Federico Baldini Luxembourg 6 543 2.3× 55 0.9× 9 0.1× 48 0.9× 135 3.0× 7 707
Irenice Coronado-Arrázola Chile 7 139 0.6× 64 1.0× 21 0.3× 36 0.7× 32 0.7× 8 329
Joselyn Jones United States 5 270 1.1× 28 0.4× 9 0.1× 50 1.0× 20 0.4× 6 506
Ashwin N. Skelly United States 5 283 1.2× 44 0.7× 9 0.1× 39 0.8× 43 1.0× 6 397
Daniel Martínez‐Martínez Spain 11 216 0.9× 61 1.0× 9 0.1× 31 0.6× 67 1.5× 15 383
Theresa L. Montgomery United States 7 252 1.1× 55 0.9× 28 0.5× 28 0.5× 42 0.9× 8 401
Soo In Choi South Korea 14 269 1.1× 46 0.7× 35 0.6× 70 1.3× 82 1.8× 26 466
Maria Rita Giuffrè Italy 10 234 1.0× 30 0.5× 25 0.4× 37 0.7× 31 0.7× 15 362

Countries citing papers authored by Muzaffer Arıkan

Since Specialization
Citations

This map shows the geographic impact of Muzaffer Arıkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffer Arıkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffer Arıkan more than expected).

Fields of papers citing papers by Muzaffer Arıkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffer Arıkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffer Arıkan. The network helps show where Muzaffer Arıkan may publish in the future.

Co-authorship network of co-authors of Muzaffer Arıkan

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffer Arıkan. A scholar is included among the top collaborators of Muzaffer Arıkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffer Arıkan. Muzaffer Arıkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arıkan, Muzaffer & Thilo Muth. (2024). gNOMO2: a comprehensive and modular pipeline for integrated multi-omics analyses of microbiomes. GigaScience. 13. 2 indexed citations
2.
Arıkan, Muzaffer, et al.. (2024). Parkinson Hastalığı Demansı ile Bağırsak Mikrobiyotasındaki Akkermansia Genomik Çeşitliliği Arasındaki İlişkinin İncelenmesi. Mikrobiyoloji Bulteni. 58(1). 13–28. 2 indexed citations
3.
Arıkan, Muzaffer, et al.. (2024). Construction of Protein Sequence Databases for Metaproteomics: A Review of the Current Tools and Databases. Journal of Proteome Research. 23(12). 5250–5262. 1 indexed citations
4.
Arıkan, Muzaffer & Thilo Muth. (2023). Integrated multi-omics analyses of microbial communities: a review of the current state and future directions. Molecular Omics. 19(8). 607–623. 33 indexed citations
5.
Arıkan, Muzaffer. (2023). An in silico Investigation of Anticancer Peptide Candidates in Fermented Food Microbiomes. DergiPark (Istanbul University). 13(1). 64–72.
6.
Arıkan, Muzaffer, Özkan Ufuk Nalbantoğlu, Nesrin Helvacı Yılmaz, et al.. (2023). Metaproteogenomic analysis of saliva samples from Parkinson’s disease patients with cognitive impairment. npj Biofilms and Microbiomes. 9(1). 86–86. 14 indexed citations
7.
Güllüoğlu, Mine, et al.. (2022). Comparison of S gene mutations in patients with occult and chronic hepatitis B virus infection. Virus Research. 318. 198855–198855. 4 indexed citations
8.
Yıldırım, Süleyman, Özkan Ufuk Nalbantoğlu, Aycan Gündoğdu, et al.. (2022). Stratification of the Gut Microbiota Composition Landscape across the Alzheimer's Disease Continuum in a Turkish Cohort. mSystems. 7(1). e0000422–e0000422. 35 indexed citations
9.
Arıkan, Muzaffer, et al.. (2022). Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson’s Disease Patients. Microbiology Spectrum. 10(1). e0235821–e0235821. 9 indexed citations
10.
Arıkan, Muzaffer, Alex Mitchell, ROBERT FINN, & Filiz Gürel. (2020). Microbial composition of Kombucha determined using amplicon sequencing and shotgun metagenomics. Journal of Food Science. 85(2). 455–464. 82 indexed citations
11.
Özer, Tuğba, Muzaffer Arıkan, Zeliha Emrence, et al.. (2015). Genomic analysis reveals the biotechnological and industrial potential of levan producing halophilic extremophile, Halomonas smyrnensis AAD6T. SpringerPlus. 4(1). 393–393. 36 indexed citations
12.
Gürses, Candan, Hülya Azaklı, Ahmet Alptekin, et al.. (2014). Mitochondrial DNA profiling via genomic analysis in mesial temporal lobe epilepsy patients with hippocampal sclerosis. Gene. 538(2). 323–327. 20 indexed citations
13.
Abacı, Neslihan, et al.. (2014). Mitochondrial mutations in patients with congenital heart defects by next generation sequencing technology. Cardiology in the Young. 25(4). 705–711. 11 indexed citations
15.
Arıkan, Muzaffer, Aris Çakiris, Neslihan Abacı, et al.. (2013). Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patients. Journal of General Virology. 94(12). 2729–2738. 8 indexed citations
16.
Üstek, Duran, Muzaffer Arıkan, Aris Çakiris, et al.. (2012). A genome-wide analysis of lentivector integration sites using targeted sequence capture and next generation sequencing technology. Infection Genetics and Evolution. 12(7). 1349–1354. 12 indexed citations
17.
Kara, Bülent, et al.. (2012). Whole mitochondrial genome analysis of a family with NARP/MILS caused by m.8993T>C mutation in the MT-ATP6 gene. Molecular Genetics and Metabolism. 107(3). 389–393. 16 indexed citations
18.
Alver, Ahmet, Ahmet Menteşe, Süleyman Caner Karahan, et al.. (2007). Increased Serum Anti-Carbonic Anhydrase II Antibodies in Patients with Graves' Disease. Experimental and Clinical Endocrinology & Diabetes. 115(5). 287–291. 29 indexed citations
19.
Erol, Ayşe, S. Mazzucato, Muzaffer Arıkan, et al.. (2003). Photo-induced transient spectroscopy of defect levels in GaInNAs. Semiconductor Science and Technology. 18(11). 968–972. 7 indexed citations
20.
Güçer, Fatih, et al.. (1997). Peritonealzytologie nach Flüssigkeitshysteroskopie bei Patientinnen mit Endometriumkarzinom. Geburtshilfe und Frauenheilkunde. 57(8). 435–439. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026